Gansu Provincial State-owned Asset Investment Group Co.,Ltd completed the acquisition of 0.80% stake in LanZhou Foci Pharmaceutical Co.,Ltd. for CNY 39 million.
October 22, 2023
Share
Gansu Provincial State-owned Asset Investment Group Co.,Ltd made a tender off to acquire a 38.37% stake in LanZhou Foci Pharmaceutical Co.,Ltd. (SZSE:002644) for CNY 1.8 billion on February 27, 2023. Under the terms, Gansu Provincial will pay CNY 9.60 per share in cash. China Dragon Securities Co., Ltd. acted as financial advisor and DeHeng Law Offices and acted as legal advisor to LanZhou Foci Pharmaceutical.
Gansu Provincial State-owned Asset Investment Group Co.,Ltd completed the acquisition of 0.80% stake in LanZhou Foci Pharmaceutical Co.,Ltd. (SZSE:002644) for CNY 39 million on October 23, 2023.
LanZhou Foci Pharmaceutical Co.,Ltd is a China-based company principally engaged in the research, development, manufacture and sale of Chinese patent drugs and large health products. The Companyâs main products are categorized into pills, tablets, granules, syrups, capsules, glue and others, including Liuwei Dihuang pills, Xiaoyao Pill, Xiangsha Yangwei pills, ginseng Gubeng Huanhao pills and other Chinese patent drugs, as well as large health products, such as Ejiao and Ejiao loafs. The Company distributes its products under the brand names Foci, Baolu and Mianshan. The Company is also involved in the cultivation, processing and marketing of Chinese herbal medicine. The Company distributes its products in domestic market and to overseas markets.
Gansu Provincial State-owned Asset Investment Group Co.,Ltd completed the acquisition of 0.80% stake in LanZhou Foci Pharmaceutical Co.,Ltd. for CNY 39 million.
LANZHOU FOCI PHARMACEUTICAL CO.,LTD. 
